Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PUMA BIOTECHNOLOGY, INC.

(PBYI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about PUMA BIOTECHNOLOGY, INC.
09/21PUMA BIOTECHNOLOGY : to Present at the Cantor Virtual Global Healthcare Conference
BU
09/20PUMA BIOTECHNOLOGY, INC.(NASDAQGS : PBYI) dropped from S&P Biotechnology Select Industry I..
CI
09/07PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
09/07PUMA BIOTECHNOLOGY : to Present at the H.C. Wainwright 23rd Annual Global Investment Confe..
BU
08/06PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
08/06PUMA BIOTECHNOLOGY : RBC Cuts PT on Puma Biotechnology to $6 From $13, Citing Nerlynx 2021..
MT
08/05PUMA BIOTECH : Q2 Earnings Snapshot
AQ
08/05PUMA BIOTECHNOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
08/05PUMA BIOTECHNOLOGY : Reports Second Quarter 2021 Financial Results
BU
08/05PUMA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
08/05Puma Biotechnology, Inc. Reports Earnings Results for the Second Quarter Ended June 30,..
CI
08/05PUMA BIOTECHNOLOGY : Earnings Flash (PBYI) PUMA BIOTECHNOLOGY Reports Q2 EPS $0.32, vs. St..
MT
08/05PUMA BIOTECHNOLOGY : Earnings Flash (PBYI) PUMA BIOTECHNOLOGY Posts Q2 Revenue $53.4M, vs...
MT
08/05EARNINGS REACTION HISTORY : Puma Biotech Inc, 60.0% Follow-Through Indicator, 16.0% Sensit..
MT
07/29PUMA BIOTECHNOLOGY : Note Purchase Agreement (Form 8-K)
PU
07/29PUMA BIOTECHNOLOGY, INC. : Entry into a Material Definitive Agreement, Creation of a Direc..
AQ
07/26PUMA BIOTECHNOLOGY : Secures $125 Million Note Purchase by Athyrium Capital
BU
07/23Puma Biotechnology, Inc. announced that it expects to receive $125 million in funding f..
CI
07/22PUMA BIOTECHNOLOGY : to Host Conference Call to Discuss Second Quarter Financial Results
BU
07/14PUMA BIOTECHNOLOGY : Departure of Directors or Principal Officers; Election of Directors; ..
PU
07/14PUMA BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
07/14Puma Biotechnology, Inc. Appoints Allison Dorval to the Board of Directors and Audit Co..
CI
07/06KNIGHT THERAPEUTICS : Says Health Canada Approves Neratinib for Treatment of HER2-Positive..
MT
07/02PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
07/01PUMA BIOTECHNOLOGY : Receives FDA Approval for Dose Escalation Label Update to Nerlynx
MT
07/01PUMA BIOTECHNOLOGY : FDA Approves Dose Escalation Label Update for Puma Biotechnology's NE..
BU
07/01FDA Approves Dose Escalation Label Update for Puma Biotechnology’s NERLYNX« in HER2-Pos..
CI
06/25PUMA BIOTECHNOLOGY, INC. : Other Events (form 8-K)
AQ
06/25PUMA BIOTECHNOLOGY, INC.(NASDAQGS : PBYI) added to Russell 3000E Growth Index
CI
06/25PUMA BIOTECHNOLOGY, INC.(NASDAQGS : PBYI) added to Russell Microcap Index
CI
06/25PUMA BIOTECHNOLOGY, INC.(NASDAQGS : PBYI) added to Russell Microcap Growth Index
CI
06/25PUMA BIOTECHNOLOGY, INC.(NASDAQGS : PBYI) added to Russell 3000E Index
CI
06/17PUMA BIOTECHNOLOGY : Expands Common Share Issuance Under Incentive Stock Options by 2 Mill..
MT
06/17PUMA BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers, Submission of Matter..
AQ
06/15INSIDER TRENDS : Puma Biotechnology Insider Continues 90-Day Selling Trend
MT
06/11INSIDER TRENDS : Puma Biotechnology Insider Continues 90-Day Selling Trend
MT
06/11INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Puma Biotechnology
MT
06/04PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
06/04PUMA BIOTECHNOLOGY : Unveils Data From Several Studies on Neratinib
MT
06/04PUMA BIOTECHNOLOGY : Presents Data from the EGFR Exon 18-mutant NSCLC Cohort of the Phase ..
BU
06/04PUMA BIOTECHNOLOGY : Presents Data Comparing Findings from the Phase II CONTROL Trial with..
BU
06/04Puma Biotechnology Presents Data from the EGFR Exon 18-mutant NSCLC Cohort of the Phase..
CI
06/04PUMA BIOTECHNOLOGY : Presents Data from the Phase III ExteNET Trial in Early Stage HER2-Po..
BU
06/04Puma Biotechnology, Inc. Presents Data from the Phase III ExteNET Trial in Early Stage ..
CI
05/19PUMA BIOTECHNOLOGY : Announces Publication of Abstracts on Neratinib for the 2021 ASCO Ann..
BU
05/07SECTOR UPDATE : Health Care Stocks Rise Ahead of Friday Open
MT
05/06PUMA BIOTECH : Q1 Earnings Snapshot
AQ
05/06PUMA BIOTECHNOLOGY : Swings to Profit in Q1 Following Surge in Sales
MT
05/06PUMA BIOTECHNOLOGY : Earnings Flash (PBYI) PUMA BIOTECHNOLOGY Reports Q1 EPS $0.55, vs. St..
MT
05/06PUMA BIOTECHNOLOGY : Earnings Flash (PBYI) PUMA BIOTECHNOLOGY Posts Q1 Revenue $98.2M, vs...
MT
05/06PUMA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
05/06PUMA BIOTECHNOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
05/06PUMA BIOTECHNOLOGY : Reports First Quarter 2021 Financial Results
BU
05/06Puma Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/06EARNINGS REACTION HISTORY : Puma Biotech Inc, 70.0% Follow-Through Indicator, 17.7% Sensit..
MT
05/04PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
04/22PUMA BIOTECHNOLOGY : to Host Conference Call to Discuss First Quarter Financial Results
BU
04/14PUMA BIOTECHNOLOGY : 2021 Annual Meeting Notice
PU
04/13PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
03/29PUMA BIOTECHNOLOGY : Chief Medical and Scientific Officer Richard Bryce Plans to Step Down
MT
03/29PUMA BIOTECHNOLOGY, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
03/29Puma Biotechnology, Inc Announces Resignation of Richard Bryce as Chief Medical and Sci..
CI
03/08PUMA BIOTECHNOLOGY : Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
BU
03/04PUMA BIOTECHNOLOGY : to Present at the Barclays Global Healthcare Conference
BU
03/02PUMA BIOTECHNOLOGY : to Present at the H.C. Wainwright Global Life Sciences Conference
BU
03/01PUMA BIOTECHNOLOGY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
02/26PUMA BIOTECHNOLOGY : and Pierre Fabre Amend NERLYNX License Agreement to Include Greater C..
AQ
02/26PUMA BIOTECHNOLOGY : 4Q-2020 Results Call – Commercial Update
PU
02/25CANbridge Pharmaceuticals, Inc. and Puma Biotechnology, Inc. Agree to Terminate Nerlynx..
CI
02/25PUMA BIOTECH : 4Q Earnings Snapshot
AQ
02/25Puma Biotechnology, Inc. Provides Sales Guidance for the First Quarter Year and Year 20..
CI
02/25PUMA BIOTECHNOLOGY : Earnings Flash (PBYI) PUMA BIOTECHNOLOGY Posts Q4 Revenue $52.6M, vs...
MT
02/25PUMA BIOTECHNOLOGY : Earnings Flash (PBYI) PUMA BIOTECHNOLOGY Posts Q4 EPS $-0.14, vs. Str..
MT
02/25PUMA BIOTECHNOLOGY : and Pierre Fabre Amend NERLYNX« License Agreement to Include Greater ..
BU
02/25PUMA BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
1  2  3  4  5  6Next
Upcoming event on PUMA BIOTECHNOLOGY, INC.